The U.S. government’s top infectious-disease expert said that early results of a closely watched clinical trial offered “quite good news” regarding a potential covid-19 therapy made by the biotechnology company…

Read more »

The post Fauci Calls Early Data From Gilead Virus-Drug Trial ‘Good News’ appeared first on Hamodia.

In related news:

  1. Gilead Disputes Report That Its Drug Flopped in Coronavirus Trial
  2. Gilead’s Remdesivir Meets Main Goal of Trial in COVID-19 Patients
  3. Coronavirus Patients Rush to Join Studies of Gilead Drug
  4. Gilead Faces Lawsuit Over Hepatitis C Drug Pricing
  5. Novartis, FDA Agree to Malaria Drug Trial Against COVID-19